These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. Sand PK; Dmochowski RR; Reddy J; van der Meulen EA J Urol; 2013 Sep; 190(3):958-64. PubMed ID: 23454404 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Desmopressin Add-On Therapy for Men with Persistent Nocturia on α-Blocker Monotherapy for Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo Controlled Study. Kim JC; Cho KJ; Lee JG; Seo JT; Kim DY; Oh SJ; Lee KS; Choo MS; Lee JZ J Urol; 2017 Feb; 197(2):459-464. PubMed ID: 27622611 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. Weiss JP; Herschorn S; Albei CD; van der Meulen EA J Urol; 2013 Sep; 190(3):965-72. PubMed ID: 23454402 [TBL] [Abstract][Full Text] [Related]
10. Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome: a Cochrane systematic review. Franco JVA; Turk T; Jung JH; Xiao YT; Iakhno S; Garrote V; Vietto V BJU Int; 2019 Aug; 124(2):197-208. PubMed ID: 30019814 [TBL] [Abstract][Full Text] [Related]
11. Low-dose Desmopressin Orally Disintegrating Tablet: Suggested Clinically Meaningful Benefit in Patients with Nocturia Due to Nocturnal Polyuria. Weiss JP; van der Meulen EA; Juul KV Eur Urol Focus; 2020 Sep; 6(5):1006-1012. PubMed ID: 30470646 [TBL] [Abstract][Full Text] [Related]
12. Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia. Jung JH; Kim J; MacDonald R; Reddy B; Kim MH; Dahm P Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012615. PubMed ID: 29161773 [TBL] [Abstract][Full Text] [Related]
13. Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study. van Kerrebroeck P; Rezapour M; Cortesse A; Thüroff J; Riis A; Nørgaard JP Eur Urol; 2007 Jul; 52(1):221-9. PubMed ID: 17280773 [TBL] [Abstract][Full Text] [Related]
14. Desmopressin add-on therapy for refractory nocturia in men receiving α-blockers for lower urinary tract symptoms. Bae WJ; Bae JH; Kim SW; Chung BH; Kim JH; Kim CS; Lee HM; Lee KS; Yoo TK; Kim SI; Byun SS; Lee JY J Urol; 2013 Jul; 190(1):180-6. PubMed ID: 23357213 [TBL] [Abstract][Full Text] [Related]
15. Long-term durability of the response to desmopressin in female and male nocturia patients. Juul KV; Klein BM; Nørgaard JP Neurourol Urodyn; 2013 Apr; 32(4):363-70. PubMed ID: 22972524 [TBL] [Abstract][Full Text] [Related]
16. A systematic review of the efficacy and safety of desmopressin for nocturia in adults. Ebell MH; Radke T; Gardner J J Urol; 2014 Sep; 192(3):829-35. PubMed ID: 24704009 [TBL] [Abstract][Full Text] [Related]
17. Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial. Yamaguchi O; Nishizawa O; Juul KV; Nørgaard JP BJU Int; 2013 Mar; 111(3):474-84. PubMed ID: 23046147 [TBL] [Abstract][Full Text] [Related]
18. Laparoscopic and robot-assisted vs open radical prostatectomy for the treatment of localized prostate cancer: a Cochrane systematic review. Ilic D; Evans SM; Allan CA; Jung JH; Murphy D; Frydenberg M BJU Int; 2018 Jun; 121(6):845-853. PubMed ID: 29063728 [TBL] [Abstract][Full Text] [Related]
19. Primary cryotherapy for localised or locally advanced prostate cancer. Jung JH; Risk MC; Goldfarb R; Reddy B; Coles B; Dahm P Cochrane Database Syst Rev; 2018 May; 5(5):CD005010. PubMed ID: 29845595 [TBL] [Abstract][Full Text] [Related]